Advantest Controls 70% of AI Chip Testing — Up 450% in a Year — and Whether the Valuation Still Makes Sense

Advantest Controls 70% of AI Chip Testing — Up 450% in a Year — and Whether the Valuation Still Makes Sense

Many investors were not aware of Advantest.


This Japanese company quietly controls roughly 70% of the global semiconductor test equipment market — the quality assurance layer that every AI chip, every HBM memory module, and every packaged GPU must pass through before it ships to a customer. As AI chips have gotten more complex and more expensive, the cost of shipping a faulty one has risen dramatically, and the demand for Advantest's equipment has followed.


The stock reflects that. Up 450% in the past year. Up roughly 250% since CSI first wrote about Advantest eleven months ago. Analyst earnings per share expectations have roughly doubled in twelve months — that is what drove the run. Advantest just reported FY2025 results of $7.1 billion in revenue and guided FY2026 to approximately $9 billion, a 26% year-over-year increase. In a test equipment market the company itself sizes at $12.5 to $13 billion for 2026, that would put Advantest's global market share approaching 70% — a level of dominance that is genuinely rare in any industry.


Nick and Kasey cover the full picture in CSI's first public video on Advantest: how it became the undisputed leader, why the test equipment slice of the $140 billion wafer fab equipment market is small but critical, what the 47x forward earnings and 56x forward free cash flow multiples actually imply, and why some analysts are already flagging a potential cycle downturn starting in 2027 even as the bulls hold firm.


The close is pure CSI. Radical moderation. Patience is a strategy. Stay in the game and survive.


What we cover:

— Advantest FY2025: $7.1B revenue and dominant market share vs. Teradyne and Aehr

— FY2026 guidance: ~$9B — approaching 70% of a $12.5–13B global TAM

— Why AI chips and packaged modules require testing — and why it is getting more expensive

— Test equipment as a slice of the $140B WFE pie — small, critical, and cyclical

— Valuation: 47x forward P/E and 56x forward FCF — what the re-rate means now

— Analyst EPS doubled in twelve months — the mechanics of why the stock ran

— The 2027 cycle risk: bear vs. bull analyst expectations laid out clearly

— Radical moderation: the CSI framework for parabolic stocks and surviving the cycle


Sponsored by fiscal.ai — the platform behind CSI's research charts. Get 15% off at fiscal.ai/csi


Disclosure: This content is for general information only and is not individual investment advice. All investing involves risk.


chipstockinvestor.com

Jaksot(431)

We Called GE Vernova Two Years Ago. Here Is What the Thesis Looks Like Now — And Whether to Keep Holding.

We Called GE Vernova Two Years Ago. Here Is What the Thesis Looks Like Now — And Whether to Keep Holding.

Two years ago, Nick called out GE Vernova when the profit margin was still near zero and the company had just been spun off from GE. The thesis was straightforward: free of the conglomerate, managemen...

30 Huhti 10min

LRCX Earnings: Record Revenue, $6.6B Guidance, and the Memory Supercycle Driving Lam Research's Best Quarter Ever

LRCX Earnings: Record Revenue, $6.6B Guidance, and the Memory Supercycle Driving Lam Research's Best Quarter Ever

Lam Research just reported its best quarter ever — and then guided the next quarter to $6.6 billion in revenue. Wall Street was expecting $6.1 billion. In this episode, Nick and Kasey break down every...

23 Huhti 9min

Why Amazon Just Spent $12 Billion on a Money-Losing Satellite Company — And the Supply Chain Stock That Benefits Most

Why Amazon Just Spent $12 Billion on a Money-Losing Satellite Company — And the Supply Chain Stock That Benefits Most

Amazon just agreed to acquire Globalstar for somewhere between $11 and $12 billion. The catch: Globalstar did $273 million in revenue last year and has never been consistently profitable. So what exac...

23 Huhti 16min

Aehr Test Systems (AEHR): We Called the $60M Stock Raise — Here's What Investors Need to Know Now

Aehr Test Systems (AEHR): We Called the $60M Stock Raise — Here's What Investors Need to Know Now

We've been following Aehr Test Systems since late 2022. We watched it run from a micro-cap to a $3 billion market cap on the back of AI accelerator hype — and we called what was coming next.In this ep...

22 Huhti 7min

ASML's Guidance Is Up. So Is the Risk.

ASML's Guidance Is Up. So Is the Risk.

ASML just raised guidance at both ends — new range is €36 to €40 billion for 2026, implying around 17% growth year over year. That's a strong result. But the data underneath it tells a more complicate...

21 Huhti 8min

The $4 Billion Hype Cycle: Why We're Passing on AXT Inc. (AXTI) and What to Buy Instead

The $4 Billion Hype Cycle: Why We're Passing on AXT Inc. (AXTI) and What to Buy Instead

AXT Inc. (AXTI) ran from a $200 million market cap to over $4 billion in a matter of months. Now it's pulled back — and a lot of retail investors are wondering if it's a buying opportunity.CSI says: n...

21 Huhti 11min

TSMC's $40 Billion Quarter: Supply Chain Risks, Intel-Tesla, and Who's Threatening the Chip King

TSMC's $40 Billion Quarter: Supply Chain Risks, Intel-Tesla, and Who's Threatening the Chip King

Chip fab capacity is maxed out — and TSMC is the biggest winner. But new risks are emerging fast.In this episode, Nick and Kasey break down TSMC's Q2 2026 earnings guidance: $39–40 billion in quarterl...

16 Huhti 9min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
rss-rahapodi
psykopodiaa-podcast
hyva-paha-johtaminen
rss-rahamania
rss-oivalluksia-rahasta-elamasta
rss-lahtijat
inderespodi
rahapuhetta
rss-startup-ministerio
rss-bisnesta-bebeja
rss-paasipodi
rss-inderes
oppimisen-psykologia
lakicast
rss-kaikki-somesta
rss-karon-grilli
rss-sisalto-kuntoon
rss-40-ajatusta-aanesta